# ANI Pharmaceuticals (ANIP) — Analyst Forecast

ANIP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/anip/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 23, 2026 | Oppenheimer | Initiated Coverage | Perform | $85.00 |
| Aug 10, 2026 | Canaccord Genuity | Maintained | Hold | $90.00 |
| Aug 10, 2026 | Guggenheim | Maintained | Buy | $119.00 |
| Jul 17, 2026 | Canaccord Genuity | Initiated Coverage | Hold | $91.00 |
| Jul 10, 2026 | Guggenheim | Maintained | Buy | $124.00 |
| Jan 16, 2026 | Guggenheim | Maintained | Buy | $124.00 |
| Dec 9, 2025 | Barclays | Initiated Coverage | Overweight | $100.00 |
| Nov 10, 2025 | Guggenheim | Maintained | Buy | $115.00 |
| Oct 9, 2025 | Truist Securities | Maintained | Hold | $90.00 |
| Sep 24, 2025 | JP Morgan | Maintained | Overweight | $115.00 |
| Sep 17, 2025 | HC Wainwright & Co. | Maintained | Buy | $121.00 |
| Sep 8, 2025 | Guggenheim | Maintained | Buy | $114.00 |
| Aug 11, 2025 | Truist Securities | Maintained | Hold | $77.00 |
| Aug 8, 2025 | HC Wainwright & Co. | Maintained | Buy | $93.00 |
| Jul 10, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $84.00 |
| May 12, 2025 | Guggenheim | Maintained | Buy | $86.00 |
| Apr 21, 2025 | Truist Securities | Maintained | Hold | $65.00 |
| Apr 11, 2025 | Guggenheim | Maintained | Buy | $86.00 |
| Mar 17, 2025 | HC Wainwright & Co. | Maintained | Buy | $94.00 |
| Mar 14, 2025 | Jefferies | Initiated Coverage | Buy | $80.00 |

## Frequently Asked Questions

### What is the latest analyst rating on ANIP?

On Sep 23, 2026, Oppenheimer initiated coverage of ANI Pharmaceuticals at Perform with a price target of $85.00.

## Similar Stocks

- [ADMA](https://www.lighthorse.io/tickers/adma) — ADMA Biologics Inc - Common Stock
- [ANVS](https://www.lighthorse.io/tickers/anvs) — Annovis Bio, Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).